Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Trips we go.
NTRR = TURD
Eddie finally going to jail in March 2022 - 3 years and $6.6 million.
Yes - they have come a long way since 2018 ($0.40/share)....btw, how is gross revenue of $1292 in the most recent quarter considered "significant revenue growth "??
CommanderInKweef - here is some history you inquired about: https://www.nasdaq.com/articles/titanic-ten-exposing-10-related-otc-stocks-2015-09-03?amp
Update on sentencing: https://www.justice.gov/usao-sdtx/us-v-farmer-et-al-victim-information
Upcoming sentencings:
Andrew Ian Farmer – 1/4/21 at 9:30 a.m.
Scott Russell Sieck – 1/11/21 at 9:30 a.m.
Carolyn Price Austin – 1/19/21 at 9:30 a.m.
Eddie Douglas Austin and Thomas Galen Massey – 1/25/21 at 9:30 a.m.
Previous sentencing:
2/3/20 - Sentencing (Brotherton) - 60 months
2/3/20 - Sentencing (Grob) - 12 months + 1 day
The company is only selling about $1k of product per month - that's only about 10-11 bottles (30 ml each) of pure CBD oil (priced at $95/bottle).
What they theoretically "could" sell (even at a higher margin) is NOWHERE near what their current results show. The optimistic view is that even at a 100x improvement on sales, the net revenue after Syd's royalty cut, G&A expenses, new employee overheads, interest expense, etc....we are still WAY underwater here.
Just to produce the inventory and pay employees, marketing, cost of goods, etc....they will have to tap into that "unlimited" authorized shares to make good on growing the business.
A simple question for you - Sydney has so far been able to attain $8.1 million dollars in additional-paid-in-capital thru issuing shares/convertible notes - what exactly have shareholders received in value anywhere near this amount??
Nope - they are only pulling in $1k per month (not $3k) gross revenue BEFORE Syd takes his 50% cut.
NTRR has a hemp license - why would they not be able to report revenue? Where exactly is that stated in either 10Q?
Unfortunately, your math is WAY off....why guess at the profitability when you can simply look at the financials - here is just a taste:
The last 6 months results:
Gross Revenues = $6.7k
Cost of goods= $1.9k
Less 40% to Sydney Jim (on first $100k of gross revenue) for Vivis = $2.7k
10% Royalty to Sydney Jim = $0.7k
Net revenue = just under $1.5k for 6 months worth of effort.
Sydney's salary for the 6 months was $50k contributing to a G&A expenses of $133k.
Interest expense was another $109k.
After netting out all other expenses and gains the net loss for 6 months was $183k.
All of this before hiring "new staff", "promotional" activities with his race car and bike team, celebrating in his "success" out in Vegas, and adding a 2nd facility.
Clearly with $9.7 million in accumulated deficit and as of July 31, 2020, the Company has negative working capital of $904,849, he is way too far in the hole to ever make this a profitable operation by only capturing about $3-4k in gross sales each quarter (no where close to your estimate of $170k/month).
Yeah - a REALLY long term - $3k in gross profits offset by $110k in overhead and operating costs.....
Rah rah !
NTRR = N-TURD
Yeah - celebrating this:
On August 30, 2019, we purchased all of the outstanding stock of Vivis Corporation, a Wyoming corporation, (“Vivis”) from Sydney Jim, our CEO. The purchase price for Vivis is $35,000 cash and a royalty of 40 percent of gross revenue until $100,000 is paid declining to 25 percent until an additional $100,000 has been paid. There will be a 10 percent royalty in perpetuity.
Convertible Preferred Stock. In January 2020, our board of directors designated 50,000 shares of our preferred stock as Convertible Preferred Stock. The Convertible Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. After the Convertible Preferred Stock has received cumulative dividends of $1,100,000, the dividend rate will reduce to 2%. The Convertible Preferred Stock is convertible into 100,000 post reverse shares of common stock of the Company. During the year ended January 31, 2020, the Company issued 50,000 shares of Convertible Preferred Stock and received cash proceeds of $250,000.
Yup - you read that right - $100k was not enough for Syd for Vivis. And yup - those super duper preferred shares are the same amount of shares POST any future reverse split - yikes!
Getting played is an understatement
NTRR = N-TURD
At least 9th place out of 10 is not "last". Wonder how much business Sydney got out of his investor paid-for paint job on his toy car (Is this part of his "vertical integration" plan??). Hope the victory lap of king crabs was complimentary for the event: https://www.instagram.com/p/CC9Cxmspx4x/?hl=en
Add in 450 million subsequent events
Ha ha! 1.8 billion shares and printing.....no dilution here..... lol
What do you mean by "no debt"? Doesn't all the convertible notes count as debt??
Not likely to be anytime soon - company has until end of August: https://ih.advfn.com/stock-market/USOTC/neutra-pk-NTRR/stock-news/82663474/current-report-filing-8-k
No one shorts a stock in this price range - the margin requirements alone would kill you for any potential upside
Convertible Preferred Stock. In January 2020, our board of directors designated 50,000 shares of our preferred stock as Convertible Preferred Stock. The Convertible Preferred Stock is entitled to receive dividends of 10% of the net profit of VIVIS Corporation. After the Convertible Preferred Stock has received cumulative dividends of $1,100,000, the dividend rate will reduce to 2%. The Convertible Preferred Stock is convertible into 100,000 post reverse shares of common stock of the Company. During the year ended January 31, 2020, the Company issued 50,000 shares of Convertible Preferred Stock and received cash proceeds of $250,000.
100% of this convertible preferred stock was issued to Sydney - this appears to be in addition to the following:
On August 30, 2019, we purchased all of the outstanding stock of Vivis Corporation, a Wyoming corporation, (“Vivis”) from Sydney Jim, our CEO. The purchase price for Vivis is $35,000 cash and a royalty of 40 percent of gross revenue until $100,000 is paid declining to 25 percent until an additional $100,000 has been paid. There will be a 10 percent royalty in perpetuity.
Wtf
"100,000 shares post reverse"....
During the period from February 1, 2020 through the date of this report, the holders of our convertible notes elected to convert $99,820 of principal and interest into 767,367,387 shares of common stock.
Current share count approaching 1.4 billion (up from around 547 million 6 months ago).....nope...no dilution going on here folks....nothing to see....move along now....
Good gawd....
Yup - highly motivated. $7.9 million in additional paid in capital and no assets (per last previous filing) to show for it and Sydney living high on the hog. A real start up rolls that money into building a business.
Regarding the 10k - they in fact were given a 45 day grace. That has since expired. The 45 day extension on the other (10q) filing is still in the grace period. There is no excuse not to have the 10k out - not when you are out and about at golf resorts and the such.
The company is delinquent on its 10k. This extension request is for the subsequent 10q which is also late. The OTC Markets "Stop" designation is related to the 10k which was due June 15 (includes previous request for extension).
Meanwhile, Sydney is improving his golf game getting right on this urgent matter: https://www.instagram.com/p/CBV62uoA5eT/?hl=en
Clearly he is busy reinvesting in the company: https://www.instagram.com/p/CBj_w1FpbPY/?hl=en
The company funds his lavish lifestyle: https://www.instagram.com/sydjim/?hl=en
It would appear the issue is with the 10K that was originally due on April 30 that had a 45 day extension due June 15. This latest 8K for another 45 day extension is related to the 1st quarter 2020 10Q. The 10K annual report for 2019 Is the one that is now delinquent.
Just catching up on posts - apologize in advance if already covered by others
We will see soon enough - 10k our on June 15
Where has the $7.9 million of additional paid in capital gone?
Where is the promised acquisition that was supposed to have happened the end of January?
Why do the financials show zero inventory and zero revenues for Vivis?
How does he intend to grow, process, market, employ staff to run this "vertically integrated" company without any resources (aside from an unlimited amount of authorized shares)?
Why have so many deals been abandoned before they even began (J3, Orgaceuticals, Artillary, etc...)
Why do the financials show that the debt was not really paid off as you indicated in your press release?
need to go much further back when Sydney was CEO of FTTN: https://seekingalpha.com/article/3488956-titanic-ten-exposing-10-related-otc-stocks
Umm...didn't see it coming? LOL - they are the ones making it run in the first place - I mean seriously think about it, acquiring millions (probably billions)of share of stock at 39% of +/- $0.0002 allows you quite a bit of risk free front money to push the stock up and sell into the lemmings....errr…..I mean investors.... who get caught up in the fever. Congrats btw - nothing wrong in making hay when money is good...just don't pretend that this is a real company with any sort of actual business plan.
My condolences to the new bag holders…..
It means that Sydney lied...the press release indicates paying down the convertible debt, but when the financials came out, we clearly see it didn't happen. In a follow up release it indicates Vivis was acquired including its inventory - that was also a lie as we see in the financials they have ZERO inventory.
<sigh> short squeeze? really? Have you ever run the math on the margin it takes to short a stock trading at +/-$0.003. When you do, come back with facts and we can discuss.
More logical answer is to review the financials instead of conjecture - clearly Sydney is issuing millions of convertible shares that are being pumped (and now dumped) onto the market - here is a flavor for the standard discount he is giving:
"The note is convertible into shares of our common stock at a 39% discount to our lowest bid price over the preceding 15 days with a floor on the conversion price of $0.00005."
you are kidding, right?: something that does not have toxic debt!!!
The 10K will be out on June 15 and we will witness how bad it really is, however, one only needs to look back at the last 10Q to get a flavor for what Sydney is doing. The company has this for a track record:
1. Cancellation of acquiring J3 Holdings
2. Cancellation of deal with Orgaceutical Co.
3. Apparent fib on repayment of short-term debt by $373,940 (latest financials (Note 8) show only $41,217 was paid in all of 2019)
4. Failure of Artillery Labs deal
5. Zero revenues for 2019 despite acquisition of Vivis and complete lack of marketing their product
6. Increasing outstanding shares in 2019 from 32 million to over 547 million+
7. Re-incorporating to Wyoming and eliminating the cap (unlimited) authorization to issue shares
8. Growing the accumulated deficit to $9.3 million+
9. Draining what little cash they started with in 2019 to near zero
10. Claiming acquisition of Vivis included inventory - but financials show zero dollar value of same
11. Failure to pay the previous CEO his salary of $80,200
12. Negative working capital of nearly $1 million for this one man show
13. Thru Oct. 2019, the Company has raised nearly $7.9 million in cash as additional paid-in-capital. Have you ever wondered where that money went and what it was spent on?: https://www.instagram.com/sydjim/?hl=en
14. The company promised by the end of January to have closed the "acquisition" of an undisclosed property for an undisclosed sum of money, with a fresh influx of unknown funding that is now being diverted for some sort of undisclosed technology tie-in, for an undisclosed purpose, presumably to warehouse inventory they do not have, in a State (Florida) that is not geographically close to its Operations (Texas), with employees to run the operation they do not have with a non-existent advertising budget to pursue their alleged retail division (Vivis) in order to pay back the CEO the hefty sum to acquire the operation (with ongoing royalty checks) that no one has ever heard of so they can claim to have another "successful" year of not actually doing anything (again) <whew>
NTRR = N-TURD
LOL - Sydney is opening up his basement stash to make hemp brownies
https://www.otcmarkets.com/filing/html?id=13810250&guid=Z0PHUWBjCL2Lw3h
Note 9. Shareholders’ Equity
Reincorporation
On August 16, 2019, the Company reincorporated from Nevada to Wyoming. The reincorporation was approved by its board of directors and by the holders of a majority of the voting rights for its common stock. There was no change in share ownership as a result of the reincorporation. Authorized shares in the Wyoming corporation are unlimited shares of common stock and 20,000,000 shares of preferred stock.
So let me get this straight, Sydney shelled out $100 to get a license to cultivate and process hemp in his basement and we are all supposed to get excited about that? He has no money, no employees, no experience growing/processing hemp, no marketing, no sales, no inventory, no crop - ZERO results and millions spent on his lavish lifestyle and he wants to "build on the success of 2019" (with your money of course) - LOL!!
"This will ensure it's in a strong position to take advantage of opportunities when the pandemic passes and consumer economicu activity resumes" - who writes this BS anyway?
Bunch of fluff...how's that Florida building acquisition going promised back in January ???
Donna Harvey probably has a few "collectors edition" Thelma dolls she could sell for a buy-in.....
I see Sydney is spending the latest round of funding well: https://www.instagram.com/p/B-Am3i-J-UY/?hl=en
This just in....Sydney Jim announces new product endorsement for Team Neutra from the pumpkin growers association of Kalamazoo: https://photos.com/featured/redneck-pumpkin-motorcycle-racer-jhorrocks.html?utm_source=GettyImages&utm_medium=website&utm_campaign=GettyImagesBuyPrint
BTW-how's that "acquisition" coming along promised by the end of January?
NTRR = N-TURD
Same ole BS from Sydney. When he was CEO of FTTN, he "sponsored" a race car for himself to own and drive - looks like he is doing the same self sponsoring at the expense of shareholders:
Meanwhile, the VIVIS CBD USA Cycling Team recently competed in its first races, finishing first in one event and second in another during the fourth annual Davy Crockett Classic, held Feb. 8 in Crockett, TX.
https://www.streetinsider.com/dr/news.php?id=16562890&gfv=1
Why would you expect any different results?:
1. Cancellation of acquiring J3 Holdings
2. Cancellation of deal with Orgaceutical Co.
3. Apparent fib on repayment of short-term debt by $373,940 (latest financials (Note 8) show only $41,217 was paid in all of 2019)
4. Failure of Artillery Labs deal
5. Zero revenues for 2019 despite acquisition of Vivis and complete lack of marketing their product
6. Increasing outstanding shares in 2019 from 32 million to over 547 million+
7. Re-incorporating to Wyoming and eliminating the cap (unlimited) authorization to issue shares
8. Growing the accumulated deficit to $9.3 million+
9. Draining what little cash they started with in 2019 to near zero
10. Claiming acquisition of Vivis included inventory - but financials show zero dollar value of same
11. Failure to pay the previous CEO his salary of $80,200
12. Negative working capital of nearly $1 million for this one man show
13. Thru Oct. 2019, the Company has raised nearly $7.9 million in cash as additional paid-in-capital. Have you ever wondered where that money went and what it was spent on?: https://www.instagram.com/sydjim/?hl=en
14. The company promised by the end of January to have closed the "acquisition" of an undisclosed property for an undisclosed sum of money, with a fresh influx of unknown funding that is now being diverted for some sort of undisclosed technology tie-in, for an undisclosed purpose, presumably to warehouse inventory they do not have, in a State (Florida) that is not geographically close to its Operations (Texas), with employees to run the operation they do not have with a non-existent advertising budget to pursue their alleged retail division (Vivis) in order to pay back the CEO the hefty sum to acquire the operation (with ongoing royalty checks) that no one has ever heard of so they can claim to have another "successful" year of not actually doing anything (again) <whew>
NTRR = N-TURD
Commentary on press release:
Neutra Corp. (NTRR) continues its efforts towards vertical integration, this time examining the potential of integrating technology into its hemp-based CBD enterprise. The company believes the time is right to add a technological dimension to its operation and that such an addition could lead to greater future growth and expansion opportunities.
BLAH, BLAH, BLAH....more meaningless jibberish about what they hope/pray/think/ponder about doing. Let's add an undefined "technology dimension" of unknown cost or benefit to our already non-existent operations with no assets, no money, no employees and no explanation as to where the millions of dollars have gone to date.
"This is a natural progression of our ongoing vertical integration push," - of course it is....more fluff about "vertical integration" with no results.
"Last year, we enjoyed success with the VIVIS acquisition that gave us a retail presence. We expect similar results in our efforts to acquire land and facilities for hemp cultivation. - At least he is being honest here stating he expects similar results of non-performance and continued dilution and degredation of shareholder value.
Adding a technology component to our growing mix would make us a stronger, more competitive company in control of the entire process from the field, to the lab to the retail store."- LOL - staying in control (of the personal ATM)….
Earlier this month, Neutra announced it had received a fresh round of private equity funding. These new funds could help the company partner with an existing CBD-related technology company or acquire one. A CBD-related technology company is typically involved in improving CBD delivery methods, such as boosting concentrations and increasing absorption rates. - WHEW - that sounds impressive..let's see what else we can throw at the wall to see what sticks. Acquiring an existing CBD-related company...you mean like Vivis - a company with no assets/employees/sales? BTW - what happened to the "acquisition" of a property that was supposed to close last month - I thought this fresh round of funding was going to be used for that?
The Hemp Business Journal has forecasted that by 2022, sales of hemp-derived products will reach $22 billion by 2022. Last year, that same market posted sales of $390 million. - yeah, and let's see...after the "success" of acquiring Vivis the sales were what again??? Oh yeah...ZERO
LOL - here's that smelly thumb you were looking for:
https://www.accesswire.com/577008/New-Funding-in-Hand-Neutra-Casts-Eye-Towards-Technology-in-Vertical-Integration-Drive
New Funding in Hand, Neutra Casts Eye Towards Technology in Vertical Integration Drive
Wednesday, February 19, 2020 12:40 PM
SUGAR LAND, TX / ACCESSWIRE / February 19, 2020 / Neutra Corp. (NTRR) continues its efforts towards vertical integration, this time examining the potential of integrating technology into its hemp-based CBD enterprise. The company believes the time is right to add a technological dimension to its operation and that such an addition could lead to greater future growth and expansion opportunities.
"This is a natural progression of our ongoing vertical integration push," said Sydney Jim, Neutra's CEO. "Last year, we enjoyed success with the VIVIS acquisition that gave us a retail presence. We expect similar results in our efforts to acquire land and facilities for hemp cultivation. Adding a technology component to our growing mix would make us a stronger, more competitive company in control of the entire process from the field, to the lab to the retail store."
Earlier this month, Neutra announced it had received a fresh round of private equity funding. These new funds could help the company partner with an existing CBD-related technology company or acquire one. A CBD-related technology company is typically involved in improving CBD delivery methods, such as boosting concentrations and increasing absorption rates.
CBD is a natural, multi-purpose hemp compound believed to offer a wide range of medical benefits. Users report relief from anxiety, lessening of the effects of seizures, slowing of neurodegenerative disorders, pain relief, and alleviation of certain cancer treatment side effects. Hemp-extracted CBD consumers also don't face the dangers of addiction, in contrast to opioid users.
The Hemp Business Journal has forecasted that by 2022, sales of hemp-derived products will reach $22 billion by 2022. Last year, that same market posted sales of $390 million.